Treatment of visceral leishmaniasis with a 10 day course of L-ampB-LRC (Bombay), a liposomal amphotericin B

Journal of Association of Physicians of India

Volumn 44, Issue 3, 1996, Pages 222-

  Bodhe, P V ^a   Pathare, A V ^a   Kshirsagar, N A ^a   Pandya, S K ^a  

^a KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIPROTOZOAL AGENT; DRUG CARRIER; LIPOSOME;

ADOLESCENT; ARTICLE; CASE REPORT; DRUG ADMINISTRATION; HUMAN; MALE; VISCERAL LEISHMANIASIS;

ADOLESCENT; AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG CARRIERS; HUMANS; LEISHMANIASIS, VISCERAL; LIPOSOMES; MALE;

EID: 0030089407     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Alving CR. Liposomes as drug carriers in leishmaniasis and malaria. Parasitology Today 1986; 2 : 101-7.
2. Croft SL, Davidson RN, Thornton EA. Liposomal amphotericin B in the treatment of visceral leishmaniasis. J Antimicrob Chemother 1991; 28 Suppl B : 111-8.
3. Gokhale PC, Kshirsagar NA, Pandya SK. Development and therapeutic application of liposomal amphotericin Current Science 1993; 65 : 448-454.
4. Gokhale PC, Kshirsagar NA, Khan MU, Pandya SK, Meisheri YV, Thakur CP, Choudhary CB. Successful treatment of resistant visceral leishmaniasis with liposomal amphotericin B (L-AmpB-LRC). Trans R Soc Trop Med Hyg 1994; 88 : 288.
5. Davidson RN, Di-Martino L, Gradoni L, et al. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Q J Med 1994; 87 : 75-81.
6. Dietze R, Milan EP, Berman JD, et al. Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion). Clin Infect Dis 1993; 17 : 981-6.